OUR PARTNERS
CONTACT US
About
Management Team
Board of Directors
Products
MYOS Canine Muscle Formula®
Physician Muscle Health Formula®
Yolked®
Scientific Research
SPORTS NUTRITION - University of Tampa Clinical Study
HEALTHY AGING – University of California at Berkeley Clinical Study
PET NUTRITION – Kansas State University Canine Clinical Study
Investor Relations
Overview
Analyst Coverage
News / Events
Company Information
Financial Information
SEC Filings
Corporate Governance
Menu
Press Releases
Overview
Analyst Coverage
News / Events
Press Releases
IR Calendar
Email Alerts
Company Information
Profile
Management Team
IR Contacts
Financial Information
Financials
Quarterly Results
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Governance Docs
Email Alerts
Fact Sheet
IR Contacts
RSS News Feed
All News
By Year:
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Sep 29, 2016
MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript
Sep 7, 2016
MYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer
Apr 22, 2016
MYOS Reports Positive Results From Fortetropin(R) Clinical Study
Mar 22, 2016
MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc.
Mar 8, 2016
MYOS Corporation Announces Election of New Directors and Appointment of Ren Ren as Global Chairman
Mar 4, 2016
MYOS Corporation Announces the Initial Closing of a Strategic Investment by RENS Technology Inc.
